Kazakhstan has taken a major step toward becoming a regional leader in advanced science with the launch of Central Asia’s first specialized Brain Institute in Almaty.

The new research and education center was officially opened at Al-Farabi Kazakh National University during celebrations marking the 80th anniversary of Kazakhstan’s National Academy of Sciences, The Caspian Post reports via Kazinform.

The institute is expected to become a key hub for cutting-edge neuroscience research, artificial intelligence applications, and medical innovation across the region.

The opening ceremony brought together leading scientists, government officials, medical experts, university representatives, and international partners, highlighting the growing importance of brain research in Kazakhstan’s scientific development strategy.

Built on the foundation of the university’s Cognitive Neuroscience Center, established in 2018, the institute represents years of investment in neuroscience research and specialist training. Researchers will have access to world-class technologies, including a 3-Tesla MRI scanner, high-density EEG systems, functional near-infrared spectroscopy (fNIRS), artificial intelligence tools, and big data analytics platforms.

Speaking at the launch, Al-Farabi Kazakh National University Rector Zhanseit Tuimebayev said the institute reflects Kazakhstan’s commitment to strengthening its scientific and technological capabilities, a priority emphasized by President Kassym-Jomart Tokayev.

President of the National Academy of Sciences of Kazakhstan, Akylbek Kurishbayev, described the institute as a milestone for domestic science and a significant contribution to the country's intellectual sovereignty and human capital development.

Led by Professor Almira Kustubayeva, the institute brings together laboratories focused on cognitive, behavioral, and computational neuroscience, as well as neurolinguistics.

Scientists will investigate some of the most complex questions about the human brain, including cognitive function, brain development, neurodegenerative diseases, emotions, decision-making processes, multilingualism, and new diagnostic biomarkers that could improve disease detection and treatment.